XML 26 R2.htm IDEA: XBRL DOCUMENT v3.5.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2016
Mar. 31, 2015
ASSETS    
Cash and cash equivalents $ 9,270,010 $ 5,014,242
Accounts receivable, net of allowance for doubtful accounts of $601,000 and $165,000 at March 31, 2016 and 2015, respectively 3,392,941 3,801,584
Other receivables 581,213 208,288
Due from Affiliates 20,505 36,397
Prepaid expenses and other current assets 293,828 792,568
Total current assets 13,558,497 9,853,079
Deferred financing costs, net 37,926 264,708
Property and equipment, net 1,247,973 582,470
Restricted cash 530,000 530,000
Intangible assets, net 2,353,212 1,377,257
Goodwill 1,622,483 2,168,833
Other assets 216,442 218,716
Total assets 19,566,533 14,995,063
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY (DEFICIT)    
Accounts payable and accrued liabilities 4,572,307 3,340,594
Medical liabilities 2,670,709 1,260,549
Notes and lines of credit payable, net of discount, current portion 188,764 327,141
Convertible notes payable, net of discount, current portion 0 1,037,818
Total current liabilities 7,431,780 5,966,102
Notes, net of discount, non-current portion 0 6,234,721
Convertible notes payable, net of discount, non-current portion 0 1,457,103
Warrant liability 2,811,111 2,144,496
Deferred rent liability 728,877 11,610
Deferred tax liability 43,479 171,215
Total liabilities $ 11,015,247 $ 15,985,247
COMMITMENTS, CONTINGENCIES AND SUBSEQUENT EVENTS
STOCKHOLDERS' EQUITY (DEFICIT)    
Common stock, par value $0.001; 100,000,000 shares authorized, 5,876,852 and 4,863,389 shares issued and outstanding at March 31, 2016 and 2015, respectively $ 5,876 $ 4,863
Additional paid-in capital 23,524,517 16,517,985
Accumulated deficit (28,684,565) (19,340,521)
Stockholders' deficit attributable to Apollo Medical Holdings, Inc. (1,269,427) (2,817,673)
Non-controlling interest 2,742,935 1,827,489
Total stockholders' equity (deficit) 1,473,508 (990,184)
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY (DEFICIT) 19,566,533 14,995,063
Series B Preferred Stock [Member]    
STOCKHOLDERS' EQUITY (DEFICIT)    
Series B Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of Series A); 555,555 and none issued and outstanding as of March 31, 2016 and 2015, respectively Liquidation preference of $4,999,995 and $0 at March 31, 2016 and 2015, respectively 3,884,745 0
Total stockholders' equity (deficit) 3,884,745 0
MEZZANINE | Series A Preferred Stock [Member]    
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY (DEFICIT)    
Series A Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of Series B); 1,111,111 and none issued and outstanding as of March 31, 2016 and 2015, respectively Liquidation preference of $9,999,999 and $0 at March 31, 2016 and 2015, respectively $ 7,077,778 $ 0